These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 16797810

  • 21. The routinization of prenatal testing.
    Suter SM.
    Am J Law Med; 2002; 28(2-3):233-70. PubMed ID: 12197464
    [No Abstract] [Full Text] [Related]

  • 22. Prenatal screening: an ethical agenda for the near future.
    de Jong A, de Wert GM.
    Bioethics; 2015 Jan; 29(1):46-55. PubMed ID: 25521973
    [Abstract] [Full Text] [Related]

  • 23. The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome.
    Alberman E, Huttly W, Hennessy E, McIntosh A.
    Prenat Diagn; 2003 Oct; 23(10):801-6. PubMed ID: 14558023
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Informed consent: providing information about prenatal examinations.
    Dahl K, Kesmodel U, Hvidman L, Olesen F.
    Acta Obstet Gynecol Scand; 2006 Oct; 85(12):1420-5. PubMed ID: 17260215
    [Abstract] [Full Text] [Related]

  • 26. Emerging issues in genetic testing in Sri Lanka.
    de Silva D.
    Indian J Med Ethics; 2007 Oct; 4(3):133-4. PubMed ID: 18624146
    [No Abstract] [Full Text] [Related]

  • 27. A meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome.
    Reid B, Sinclair M, Barr O, Dobbs F, Crealey G.
    Soc Sci Med; 2009 Dec; 69(11):1561-73. PubMed ID: 19783085
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Reconsidering prenatal screening: an empirical-ethical approach to understand moral dilemmas as a question of personal preferences.
    García E, Timmermans DR, van Leeuwen E.
    J Med Ethics; 2009 Jul; 35(7):410-4. PubMed ID: 19567688
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications.
    Hall A, Bostanci A, Wright CF.
    Public Health Genomics; 2010 Jul; 13(4):246-55. PubMed ID: 20395693
    [Abstract] [Full Text] [Related]

  • 40. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
    Gourounti K, Sandall J.
    Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.